RxDoctor Payments Data

Letisha Benitez, APRN

Acute Care · Stuart, FLNPI 1861267890

Payments from drug & device makers

$1,755in general payments, 2019–2025

Across 47 payments — averaging $37.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$415
  • Kestra Medical Technology Services, Inc.$336
  • Boston Scientific$283
  • Novartis$163
  • Amgen$129
  • Actelion Pharmaceuticals US, Inc.$122
  • plus $307 from 9 others

What the payments were for

  • Food & beverage$1,755100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,755 in reported general payments places this provider in the 80th percentile of 1,150 acute care providers in Florida.

See all acute care providers in Florida

Medicare billing

Part B allowed, 2024
$3,473
Medicare patients
31
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban16$11,591
Metoprolol Succinate29$323
ClopidogrelClopidogrel Bisulfate13$230
Potassium Chloride16$190
Rosuvastatin Calcium12$150
Hydralazine Hcl13$149
Lisinopril22$146
Amlodipine Besylate30$142
Metoprolol Tartrate21$137
Atorvastatin Calcium11$117
Furosemide27$78

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$38$11,59116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,150 acute care providers in Florida.

Other acute care in Stuart

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →